ArticleOncoimmunology
LAG-3 confers poor prognosis and its blockade reshapes antitumor response in head and neck squamous cell carcinoma.
Wei-Wei Deng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
91 papers cite itlatest 60 shown
pooled itcites it